Long near 550-60 SL 476 tgt 840+ DISCLAIMER:There is no guarantee of profits or no exceptions from losses. The study provided is solely the personal views of my research. You are advised to rely on your judgment while investing/Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. Seek help of your...
Only for Educational Purpose : Go Long above 1351.4 for the target of 1381.9 with SL 1321 Reasons to go Long : 1. On a daily timeframe if we draw the Fibonacci retracement tool from recent swing low (point A) to recent swing high (point B) then we see stock took support from 0.618 Fibonacci level. 2. Also a bullish candlestick pattern, Bullish Engulfing...
Buy gold above 47600 Target 1- 47850 Target 2- 48000 Target 3- 48400 Stoploss- 47350 (Closing Basis)
BPCL at a good point in terms of risk-reward. One can enter here with 400 as WCB stop loss. The target is near 470-480. If it clears that then can head to 520-530. Also, it has retraced till 50% and has formed a Bullish candle on weekly time-frame there.
The stock seems to be near to 61.2 % fibonnaci Retracement Levels also the stock price looks near a support . Please verify my small research . It would be really helpful.
KOTAK BANK EQUITY levels ...26/04/2021 (D candle)
LIC HF EQUITY levels ...26/04/2021 (D candle)
BEL EQUITY levels ...26/04/2021 (D candle)
BATA INDIA EQUITY levels ...26/04/2021 (D candle)
BANKNIFTY Resistance: 32624 - 32964 - 33396 Support: 32148 - 31853 - 31376 - 31036 - 30604
NIFTY Resistance: 14552 - 14631 - 14731 Support: 14442 - 14373 - 14263 - 14184 - 14085
Observed reversal from 61.8 level in Fibonacci retracement with a bullish engulfing candle on 22nd April. Possible upside to 425 with stop loss at 325.
risky buy buy above 295.6 with stop 287 targets as per fibo levels in chart disclaimer - trade @ own risk
All levels are marked in the chart only. Cadila Healthcare can begin a new bull run on technical levels......analysis is also backed by news of Virafin(an antiviral produced by Cadila Healthcare) being given emergency approval for treatment of moderate COVID-19 patients. Volume has also increased drastically. Cadila has also given closing above a trendline...
very important resistance point at 47k if we lose the 47k it can be harder to back to the upward trend
Cadila Healthcare perfectly retraced from 0.618 Fibonacci level. With the increase in volume as price moved up and the news of Virafin getting approval for treatment of moderate COVID-19 patients Cadila seems to be in a very strong up move. On Fib Extension 1.618 level(Rs. 640) can be reached very shortly. Cadila has also given closing near a long term trendline...
Inverse Head & Shoulder Pattern seen on Monthly Chart, Breakout above 95.5 (Neckline) 95.5 is also Resistance on Monthly Chart. Stock will be breaking out after 9 Years of accumulation mode. Huge Volume seen in last 5 months confirming accumulation at lower levels. If Breakout is successful then expect Fibo Target of 147.3 and 225.5 soon. Excepted Time Frame: 2...
Sell Tatamotors if break 276 tgt 270/250 buy above 305/6/7/8/9 tgt 321/26/35/